-

Global Mortgage Lending Market Report to 2031 - Featuring BNP Paribas, Qatar National Bank, Rocket Mortgage and Sofi Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Mortgage Lending Market By Type of Mortgage Loan, By Mortgage Loan Terms, By Interest Rate, By Provider: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has been added to ResearchAndMarkets.com's offering.

According to this report the mortgage lending market was valued at $11,487.23 billion in 2021, and is estimated to reach $27,509.24 billion by 2031, growing at a CAGR of 9.5% from 2022 to 2031.

A mortgage loan, often known as a mortgage, is a loan utilized by either real estate buyers or current property owners to acquire money for any purpose while enforcing a lien on the real estate being mortgaged. In addition, a mortgage is a loan provided by a bank or other financial organization to aid in the purchase of a house. The actual house is the mortgage's collateral. In other words, if the borrower stops paying the lender on a regular basis and defaults on the loan, the lender can sell the house to recuperate its losses.

To speed up and simplify the front-to-back-end mortgage application process for customers, the mortgage sector has been steadily implementing technology. In addition, the availability of mortgage services on smartphones applications for underwriting processes is boosting the growth of the market.

However, higher interest rates on mortgages loans and higher fees for mortgage broker are some of the factors that hamper the market growth. On the contrary, adoption of APIs and open banking in mortgage lending industry is expected to boost the market growth in upcoming years. Moreover, increasing implementation of artificial intelligence (AI) and machine learning (ML) for automation of underwriting and application processes is anticipated to create lucrative opportunities for the market to grow in future.

Key Benefits

  • The study provides in-depth analysis of the global mortgage lending market along with current trends and future estimations to illustrate the imminent investment pockets.
  • Information about key drivers, restrains, & opportunities and their impact analysis on the global mortgage lending market size are provided in the report.
  • The Porter's five forces analysis illustrates the potency of buyers and suppliers operating in the industry.
  • The quantitative analysis of the global mortgage lending market from 2021 to 2031 is provided to determine the market potential.

Key Market Segments

By Type of Mortgage Loan

  • Conventional Mortgage Loans
  • Jumbo Loans
  • Government-insured Mortgage Loans
  • Others

By Mortgage Loan Terms

  • 30-year Mortgage
  • 20-year Mortgage
  • 15-year Mortgage
  • Others

By Interest Rate

  • Fixed-rate Mortgage Loan
  • Adjustable-rate Mortgage Loan

By Provider

  • Primary Mortgage Lender
  • Primary Mortgage Lender
  • Banks
  • Credit Unions
  • NBFC's
  • Others
  • Secondary Mortgage Lender

By Region

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia-Pacific
  • LAMEA
  • Latin America
  • Middle East
  • Africa

Key Market Players

  • Ally
  • Bank of America Corporation
  • BNP Paribas
  • China Zheshang Bank
  • Federal National Mortgage Association (FNMA)
  • JP Morgan & Chase
  • Mitsubishi UFJ Financial Group
  • PT Bank Central Asia Tbk
  • Qatar National Bank
  • Royal Bank of Canada
  • Rocket Mortgage, LLC
  • Sofi
  • Standard Chartered PLC
  • Truist financial corporation
  • Clear Capital
  • Roostify
  • Mr. Cooper

For more information about this report visit https://www.researchandmarkets.com/r/lipy2k

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Blockchain and Non-Fungible Tokens new Technologies and the Relevant Law Training Course: Core Principles, Smart Contracts, NFTs, and Decentralized Finance Explained (Online Event: May 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Blockchain and Non-Fungible Tokens: Understanding new Technologies and the Relevant Law Training Course (May 20, 2026)" training has been added to ResearchAndMarkets.com's offering. Blockchain is a new technology that could potentially have major impacts in a wide range of industries. It has the potential to dramatically change how business is conducted - but there is no one central authority controlling blockchain, everyone has access to the same information. Are...

Writing Clinical Research with Integrity Training Course: Principles of Medical and Scientific Writing, Including Ethical Standards, Data Integrity, and Plagiarism Prevention (Online: Apr 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Writing Clinical Research with Integrity Training Course (Apr 20, 2026)" training has been added to ResearchAndMarkets.com's offering. This course covers key principles of medical and scientific writing, including ethical standards, data integrity, and plagiarism prevention. Participants will learn how to tailor content for various audiences, structure documents (e.g., manuscripts, protocols), and adhere to writing standards such as clarity, consistency, and correc...

In-Vitro Diagnostic Regulation (EU) 2017/746 Introduction Training Course (Online Event: Apr 16th - Apr 17th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Introduction to the In-Vitro Diagnostic Regulation (IVDR) Training Course (Apr 16th - Apr 17th, 2026)" training has been added to ResearchAndMarkets.com's offering. The In-Vitro Diagnostic Regulation (EU) 2017/746, which came into force in May 2017 with a transition period of five years, is intended to strengthen the current approval system for in-vitro diagnostics and makes substantial changes to the existing IVD Directive (98/79/EC) legislation. The Regulation in...
Back to Newsroom